153 related articles for article (PubMed ID: 23015650)
1. A new dawn of anticoagulation for patients with antiphospholipid syndrome?
Giles I; Khamashta M; D'Cruz D; Cohen H
Lupus; 2012 Oct; 21(12):1263-5. PubMed ID: 23015650
[No Abstract] [Full Text] [Related]
2. The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.
Son M; Wypasek E; Celinska-Lowenhoff M; Undas A
Thromb Res; 2015 May; 135(5):1035-6. PubMed ID: 25669601
[No Abstract] [Full Text] [Related]
3. Anticoagulation therapy in the antiphospholipid syndrome: recent advances.
Ng HJ; Crowther MA
Curr Opin Pulm Med; 2005 Sep; 11(5):368-72. PubMed ID: 16093807
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
[TBL] [Abstract][Full Text] [Related]
6. Intensity of warfarin coagulation in the antiphospholipid syndrome.
Crowther M; Crowther MA
Curr Rheumatol Rep; 2010 Feb; 12(1):64-9. PubMed ID: 20425536
[TBL] [Abstract][Full Text] [Related]
7. The future landscape of anticoagulation management.
Bussey HI
Pharmacotherapy; 2011 Dec; 31(12):1151-5. PubMed ID: 22122177
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
[TBL] [Abstract][Full Text] [Related]
9. The lesser known side-effect of warfarin: warfarin-induced venous limb gangrene.
Sheng GH; Aronowitz P
Mayo Clin Proc; 2014 May; 89(5):e47. PubMed ID: 24797650
[No Abstract] [Full Text] [Related]
10. The antiphospholipid syndrome: from pathophysiology to treatment.
Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
[TBL] [Abstract][Full Text] [Related]
11. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome.
Les I; Ruiz-Irastorza G; Khamashta MA
Semin Thromb Hemost; 2012 Jun; 38(4):339-47. PubMed ID: 22467528
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and treatment of the antiphospholipid antibody syndrome.
Petri M
Med Clin North Am; 1997 Jan; 81(1):151-77. PubMed ID: 9012759
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo V; Denas G; Zoppellaro G; Jose SP; Hoxha A; Ruffatti A; Andreoli L; Tincani A; Cenci C; Prisco D; Fierro T; Gresele P; Cafolla A; De Micheli V; Ghirarduzzi A; Tosetto A; Falanga A; Martinelli I; Testa S; Barcellona D; Gerosa M; Banzato A
Blood; 2018 Sep; 132(13):1365-1371. PubMed ID: 30002145
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
Pierangeli SS; Erkan D
Lupus; 2010 Apr; 19(4):475-85. PubMed ID: 20353991
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
Dufrost V; Risse J; Zuily S; Wahl D
Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
[TBL] [Abstract][Full Text] [Related]
16. Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up.
Naru T; Khurshid M; Nazir Z
J Pak Med Assoc; 2006 Feb; 56(2):84-6. PubMed ID: 16555643
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome and challenges with direct oral anticoagulants.
Booth S; Burton K; Hunt B; Desborough M
Br J Hosp Med (Lond); 2020 May; 81(5):1-11. PubMed ID: 32468937
[TBL] [Abstract][Full Text] [Related]
18. Heparin use during pregnancy.
Houman MH; Ksontini-Smida I; Miled M
Tunis Med; 2002 Jun; 80(6):297-305. PubMed ID: 12534039
[TBL] [Abstract][Full Text] [Related]
19. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
20. Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).
Cuadrado MJ
Curr Rheumatol Rep; 2002 Oct; 4(5):392-8. PubMed ID: 12217243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
